- Home
- IMUX vs RMBL Comparison
IMUX vs RMBL Comparison
Compare IMUX & RMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- RMBL
- Stock Information
- Founded
- IMUX 2016
- RMBL 2013
- Country
- IMUX United States
- RMBL United States
- Employees
- IMUX N/A
- RMBL N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- RMBL EDP Services
- Sector
- IMUX Health Care
- RMBL Technology
- Exchange
- IMUX Nasdaq
- RMBL Nasdaq
- Market Cap
- IMUX 67.8M
- RMBL 81.4M
- IPO Year
- IMUX N/A
- RMBL N/A
- Fundamental
- Price
- IMUX $0.96
- RMBL $2.16
- Analyst Decision
- IMUX Strong Buy
- RMBL Hold
- Analyst Count
- IMUX 5
- RMBL 4
- Target Price
- IMUX $7.50
- RMBL $4.50
- AVG Volume (30 Days)
- IMUX 1.1M
- RMBL 60.3K
- Earning Date
- IMUX 08-11-2025
- RMBL 08-06-2025
- Dividend Yield
- IMUX N/A
- RMBL N/A
- EPS Growth
- IMUX N/A
- RMBL N/A
- EPS
- IMUX N/A
- RMBL N/A
- Revenue
- IMUX N/A
- RMBL $1,146,100,000.00
- Revenue This Year
- IMUX N/A
- RMBL N/A
- Revenue Next Year
- IMUX N/A
- RMBL $8.09
- P/E Ratio
- IMUX N/A
- RMBL N/A
- Revenue Growth
- IMUX N/A
- RMBL N/A
- 52 Week Low
- IMUX $0.56
- RMBL $1.46
- 52 Week High
- IMUX $2.11
- RMBL $7.06
- Technical
- Relative Strength Index (RSI)
- IMUX 55.60
- RMBL 39.32
- Support Level
- IMUX $0.94
- RMBL $2.32
- Resistance Level
- IMUX $1.18
- RMBL $2.56
- Average True Range (ATR)
- IMUX 0.08
- RMBL 0.18
- MACD
- IMUX 0.01
- RMBL -0.05
- Stochastic Oscillator
- IMUX 40.95
- RMBL 0.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.